14th Annual Western AF Symposium Agenda
Western A-Fib Symposium prides itself on a dynamic and supremely current agenda with leading experts. For this reason, the program is continually transforming as it incorporates breaking updates in the field. You are welcome to check this document up to the program date for such changes.
Please note that all faculty have been asked to submit disclosures of all potential conflicts of interest that arise from financial relationships with a commercial interest(s). (A commercial interest is defined as any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients.) All such disclosures are noted under the ‘Faculty’ tab on this website.
Thursday, February 25, 2021
| 14:30 – 16:30 | FELLOWS TRAINING PROGRAM (NON-CME Program by Cardiva Medical; Separate from WAF) |
| 17:30-19:30 | RECEPTION & PRESENTATIONS BY TOP EP FELLOW SCHOLARSHIP CONTESTANTS Hosted by Medtronic |
| 19:00 | FIRESIDE CHATS |
| Hosted by Acutus | |
| *Thursday events are not part of the main WAF program nor are they designated for CME |
Thursday, February 25, 2021
| ||
| 17:30-19:30 | ||
| RECEPTION & PRESENTATIONS BY TOP EP FELLOW SCHOLARSHIP CONTESTANTS Hosted by Medtronic | ||
| 19:00 | ||
| FIRESIDE CHATS Hosted by Acutus | ||
| *Thursday events are not part of the main WAF program nor are they designated for CME. |
Friday, February 26, 2021
| 07:00 – 07:30 | REGISTRATION, EXHIBITS & BREAKFAST SNACKS |
| 07:30 – 07:45 | WELCOME & INTRODUCTIONS Nassir F. Marrouche, MD |
Friday, February 26, 2021
| 07:00 – 07:30 |
| REGISTRATION, EXHIBITS & BREAKFAST SNACKS |
| 07:30 – 07:45 |
| WELCOME & INTRODUCTIONS Nassir F. Marrouche, MD |
Session 1
Chairs: Hugh Calkins, MD; Melvin Scheinman, MD
| 07:45 – 07:55 | ATRIAL FIBRILLATION: MAJOR BREAKTHROUGHS OF 2020 Eric N. Prystowsky, MD |
| 07:55 – 08:05 | HOW MACHINE LEARNING IS TAKING OVER STRATEGIES FOR AF SCREENING Hamid Ghanbari, MD |
| 08:05 – 08:15 | THE NEW ESC 2020 AF GUIDELINES Gerhard Hindricks, MD, MBA, ProfDr. |
| 08:15 – 08:25 | HOW I CHANGED MY PRACTICE AFTER EAST-AF John Mandrola, MD |
| 08:25 – 08:35 | TARGETING ATRIAL FIBROSIS PROGRESSION AFTER ABLATION OF ATRIAL FIBRILLATION: THE EDORA TRIAL DESIGN Lilas Dagher, MD |
| 08:35 – 08:55 | OPEN DISCUSSION |
Session 1
Chairs: Hugh Calkins, MD; Melvin Scheinman, MD
| 07:45 – 07:55 |
| ATRIAL FIBRILLATION: MAJOR BREAKTHROUGHS OF 2020 Eric N. Prystowsky, MD |
| 07:55 – 08:05 |
| HOW MACHINE LEARNING IS TAKING OVER STRATEGIES FOR AF SCREENING Hamid Ghanbari, MD |
| 08:05 – 08:15 |
| THE NEW ESC 2020 AF GUIDELINES Gerhard Hindricks, MD, MBA, ProfDr. |
| 08:15 – 08:25 |
| HOW I CHANGED MY PRACTICE AFTER EAST-AF John Mandrola, MD |
| 08:25 – 08:35 |
| TARGETING ATRIAL FIBROSIS PROGRESSION AFTER ABLATION OF ATRIAL FIBRILLATION: THE EDORA TRIAL DESIGN Lilas Dagher, MD |
| 08:35 – 08:55 |
| OPEN DISCUSSION |
Session 2
MODERATORS: Ahmad Abdul-Karim, MD; Gregory F. Michaud, MD
| 08:55 – 09:55 | ROUNDTABLE: MY INITIAL APPROACH TO PATIENTS WITH PERSISTENT AF: NO TRIALS SUPPORTING MORE THAN PVI Mikhael El-Chami, MD, FHRS; Uzodinma Emerenini, MD; Alexies Ramirez, MD, FHRS; Gaston R. Vergara, MD |
| 09:55 – 10:10 | BREAK & EXHIBITS |
Session 2
MODERATORS: Ahmad Abdul-Karim, MD; Gregory F. Michaud, MD
| 08:55 – 09:55 |
| ROUNDTABLE: MY INITIAL APPROACH TO PATIENTS WITH PERSISTENT AF: NO TRIALS SUPPORTING MORE THAN PVI Mikhael El-Chami, MD; Uzodinma Emerenini, MD; Alexies Ramirez, MD, FHRS; Gaston R. Vergara, MD |
| 09:55 – 10:10 |
| BREAK & EXHIBITS |
Session 3
CHAIRS: Melvin Scheinman, MD; Christian Mahnkopf, MD
| 10:10 – 10:20 | EPI/ENDO ABLATION FOR TREATMENT OF PERSISTENT ATRIAL FIBRILLATION: THE ‘CONVERGE’ TRIAL David D. De Lurgio, MD, FACC, FHRS |
| 10:20 – 10:30 | ATRIAL FIBRILLATION ABLATION: NEW TOOLS & STRATEGIES FOR LESION CREATION & EVALUATION Pierre Jais, MD |
| 10:30 – 10:40 | PULSED FIELD ABLATION: THE PHYSICS David E. Haines, MD |
| 10:40 – 10:50 | ICE-GUIDED LEFT ATRIAL APPENDAGE CLOSURE IMPLANTATION: FEASIBILITY Walid Saliba, MD |
| 10:50 – 11:15 | OPEN DISCUSSION |
| 11:15 – 12:30 | LUNCH & EXHIBITS |
Session 3
CHAIRS: Melvin Scheinman, MD; Christian Mahnkopf, MD
| 10:10 – 10:20 |
| EPI/ENDO ABLATION FOR TREATMENT OF PERSISTENT ATRIAL FIBRILLATION: THE ‘CONVERGE’ TRIAL David D. De Lurgio, MD, FACC, FHRS |
| 10:20 – 10:30 |
| ATRIAL FIBRILLATION ABLATION: NEW TOOLS & STRATEGIES FOR LESION CREATION & EVALUATION Pierre Jais, MD |
| 10:30 – 10:40 |
| PULSED FIELD ABLATION: THE PHYSICS David E. Haines, MD |
| 10:40 – 10:50 |
| ICE-GUIDED LEFT ATRIAL APPENDAGE CLOSURE IMPLANTATION: FEASIBILITY Walid Saliba, MD |
| 10:50 – 11:15 |
| OPEN DISCUSSION 11:15 – 12:30 |
| 11:30 – 12:15 |
MEET THE EXPERTS
| Chair: Hugh Calkins, MD | |
| 11:30 – 12:15 | ROLE OF NON-PV TRIGGERS: IMPORTANCE OF THE POSTERIOR LA Amin Al-Ahmad, MD |
| HOW TO INCORPORATE THE RESULTS OF THE CONVERGE TRIAL & THE EVOLUTION OF THE CONVERGENT APPROACH David D. De Lurgio, MD, FACC, FHRS | |
| ARRHYTHMOGENESIS OF THE LAA: IMPACT OF THE AMAZE TRIAL Suneet Mittal, MD | |
| FUTURE OF HYBRID APPROACHES David J. Wilber, MD |
Meet The Experts
| Chair: Hugh Calkins, MD |
| 11:30 – 12:15 |
| ROLE OF NON-PV TRIGGERS: IMPORTANCE OF THE POSTERIOR LA Amin Al-Ahmad, MD |
| HOW TO INCORPORATE THE RESULTS OF THE CONVERGE TRIAL & THE EVOLUTION OF THE CONVERGENT APPROACH David D. De Lurgio, MD, FACC, FHRS |
| ARRHYTHMOGENESIS OF THE LAA: IMPACT OF THE AMAZE TRIAL Suneet Mittal, MD |
| FUTURE OF HYBRID APPROACHES David J. Wilber, MD |
Session 4
Chairs: Dhanunjaya “DJ” Lakkireddy, MD; Christopher McGann, MD
| 12:30 – 12:40 | EARLY AF-ABLATION IMPROVES OUTCOMES: MULTI-CENTER TRIALS Oussama Wazni, MD |
| 12:40 – 12:50 | SAFETY, EFFECTIVENESS & CLINICAL BENEFITS OF PsAF TREATMENT USING CF RF ABLATION: |
| 12:50 – 13:00 | NEW CLINICAL & COST BENEFITS OF EARLY AF TREATMENT Karl Heinz Kuck, MD |
| 13:00 – 13:10 | THE SAFETY & EFFECTIVENESS OF PVI WITH STANDARDIZED ABLATION INDEX WORKFLOW (VISTAX) Mattias Duytschaever, MD |
| 13:10 – 13:30 | OPEN DISCUSSION |
Session 4
Chairs: Dhanunjaya “DJ” Lakkireddy, MD; Christopher McGann, MD
| 12:30 – 12:40 |
| EARLY AF-ABLATION IMPROVES OUTCOMES: MULTI-CENTER TRIALS Oussama Wazni, MD |
| 12:40 – 12:50 |
SAFETY, EFFECTIVENESS & CLINICAL BENEFITS OF PsAF TREATMENT USING CF RF ABLATION: |
| 12:50 – 13:00 |
| NEW CLINICAL & COST BENEFITS OF EARLY AF TREATMENT Karl Heinz Kuck, MD |
| 13:00 – 13:10 |
| THE SAFETY & EFFECTIVENESS OF PVI WITH STANDARDIZED ABLATION INDEX WORKFLOW (VISTAX) Mattias Duytschaever, MD |
| 13:10 – 13:30 |
| OPEN DISCUSSION |
Session 5
CHAIRS: Tina Baykaner, MD, MPH; Mark Ibrahim, MD, FACC
| 13:30 – 13:40 | REFINING PATIENT SELECTION FOR AF ABLATION IN HF: RATIONALE FOR CASTLE-AF II Nassir F. Marrouche, MD |
| 13:40 – 13:50 | HOW DIGITAL HEALTH TOOLS ARE GLOBALIZING & IMPROVING AF SCREENING: PATIENT PERSPECTIVES Trudie C. A. Lobban, MBE, FRCP, Edin |
| 13:50 – 14:00 | ATRIAL IMAGING USING CARDIAC MRI: OVERCOMING CHALLENGES Eugene Kholmovski, PhD |
| 14:00 – 14:10 | CARDIAC MRI FOR ATRIAL IMAGING IN AF: ESC GUIDELINES & SCALABILITY Saman Nazarian, MD, PhD |
| 14:10 – 14:20 | LIFESTYLE MODIFICATION IN AF GUIDELINES, BUT NOT IMPLEMENTED IN CLINICAL PRACTICE! WHY? Prashanthan Sanders, MBBS, PhD |
| 14:20 – 14:40 | OPEN DISCUSSION |
| 14:40 – 14:55 | BREAK & EXHIBITS |
Session 5
CHAIRS: Tina Baykaner, MD, MPH; Mark Ibrahim, MD, FACC
| 13:30 – 13:40 |
| REFINING PATIENT SELECTION FOR AF ABLATION IN HF: RATIONALE FOR CASTLE-AF II Nassir F. Marrouche, MD |
| 13:40 – 13:50 |
| HOW DIGITAL HEALTH TOOLS ARE GLOBALIZING & IMPROVING AF SCREENING: PATIENT PERSPECTIVES Trudie C. A. Lobban, MBE, FRCP, Edin |
| 13:50 – 14:00 |
| ATRIAL IMAGING USING CARDIAC MRI: OVERCOMING CHALLENGES Eugene Kholmovski, PhD |
| 14:00 – 14:10 |
| CARDIAC MRI FOR ATRIAL IMAGING IN AF: ESC GUIDELINES & SCALABILITY Saman Nazarian, MD, PhD |
| 14:10 – 14:20 |
| LIFESTYLE MODIFICATION IN AF GUIDELINES, BUT NOT IMPLEMENTED IN CLINICAL PRACTICE! WHY? Prashanthan Sanders, MBBS, PhD |
| 14:20 – 14:40 |
| OPEN DISCUSSION |
| 14:40 – 14:55 |
| BREAK & EXHIBITS |
Session 6
CHAIRS: Thomas F. Deering, MD, MBA, FHRS, FACC, FACP; Christopher J. McGann, MD
| 14:55 – 15:05 | CARDIAC MRI, CTA OR TEE FOR LEFT ATRIAL APPENDAGE THROMBUS EVALUATION Mark Ibrahim, MD, FACC |
| 15:05 – 15:15 | SHORT & LONG -TERM ENDPOINTS OF MY AF ABLATION PROCEDURE IN 2021 Francis E. Marchlinski, MD |
| 15:15 – 15:25 | PHARMACOGENETIC TARGETING FOR AF PREVENTION IN AT-RISK HEART FAILURE PATIENTS Michael R. Bristow, MD, PhD |
| 15:25 – 15:35 | PILL-IN-THE-POCKET FOR AF STROKE PREVENTION: AVAILABLE EVIDENCE & FUTURE TRIALS Rod Passman, MD, MSCE |
| 15:35-15:55 | OPEN DISCUSSION |
Session 6
CHAIRS: Thomas F. Deering, MD, MBA, FHRS, FACC, FACP; Christopher J. McGann, MD
| 14:55 – 15:05 |
| CARDIAC MRI, CTA OR TEE FOR LEFT ATRIAL APPENDAGE THROMBUS EVALUATION Mark Ibrahim, MD, FACC |
| 15:05 – 15:15 |
| SHORT & LONG -TERM ENDPOINTS OF MY AF ABLATION PROCEDURE IN 2021 Francis E. Marchlinski, MD |
| 15:15 – 15:25 |
| PHARMACOGENETIC TARGETING FOR AF PREVENTION IN AT-RISK HEART FAILURE PATIENTS Michael R. Bristow, MD, PhD |
| 15:25 – 15:35 |
| PILL-IN-THE-POCKET FOR AF STROKE PREVENTION: AVAILABLE EVIDENCE & FUTURE TRIALS Rod Passman, MD, MSCE |
| 15:35-15:55 |
| OPEN DISCUSSION |
Session 7
MODERATORS: Amin Al-Ahmad, MD; Jeanne E. Poole, MD
| 15:55 – 16:05 | HOW MUCH AF GETS MY ATTENTION? THE BURDEN LESSON |
| 16:05 – 16:15 | DRONEDARONE BEYOND AF SUPPRESSION Carina Blomstrom-Lundquist, MD, PhD |
| 16:15 – 16:25 | MACHINE LEARNING APPROACHES FOR DIGITAL HEALTH – UNCOVERING HIDDEN SIGNALS Chan Ho Lim, MS |
| 16:25 – 16:35 | THE ESUS PATIENT: WHEN & HOW TO MONITOR FOR SUBCLINICAL AF Suneet Mittal, MD |
| 16:35 – 16:45 | APPLE HEART & HEARTLINE: HOW THESE TRIALS WILL CHANGE CLINICAL PRACTICE Mintu Turakhia, MD |
| 16:45 – 17:05 | OPEN DISCUSSION |
Session 7
MODERATORS: Amin Al-Ahmad, MD; Jeanne E. Poole, MD
| 15:55 – 16:05 |
HOW MUCH AF GETS MY ATTENTION? THE BURDEN LESSON |
| 16:05 – 16:15 |
| DRONEDARONE BEYOND AF SUPPRESSION Carina Blomstrom-Lundquist, MD, PhD |
| 16:15 – 16:25 |
| MACHINE LEARNING APPROACHES FOR DIGITAL HEALTH – UNCOVERING HIDDEN SIGNALS Chan Ho Lim, MS |
| 16:25 – 16:35 |
| THE ESUS PATIENT: WHEN & HOW TO MONITOR FOR SUBCLINICAL AF Suneet Mittal, MD |
| 16:35 – 16:45 |
| APPLE HEART & HEARTLINE: HOW THESE TRIALS WILL CHANGE CLINICAL PRACTICE Mintu Turakhia, MD |
| 16:45 – 17:05 |
| OPEN DISCUSSION |
Session 8
MODERATORS: John D. Day, MD
| 17:05 – 17:45 | ROUNDTABLE: ELECTROPHYSIOLOGY & DIGITAL HEALTH DURING A PANDEMIC: HOW DID COVID-19 IMPACT MY CURRENT AND FUTURE CLINICAL PRACTICE? Tina Baykaner, MD, MPH; Lilas Dagher, MD; Janet K. Han, MD; Christian Mahnkopf, MD; Suneet Mittal, MD; Elaine Y. Wan, MD |
Session 8
MODERATORS: John D. Day, MD
| 17:05 – 17:45 |
| ROUNDTABLE: ELECTROPHYSIOLOGY & DIGITAL HEALTH DURING A PANDEMIC: HOW DID COVID-19 IMPACT MY CURRENT AND FUTURE CLINICAL PRACTICE? Tina Baykaner, MD, MPH; Lilas Dagher, MD; Janet K. Han, MD; Christian Mahnkopf, MD; Suneet Mittal, MD; Elaine Y. Wan, MD |
Session 9
CHAIRS: Edward J. Schloss, MD, FHRS; Bassam Wanna, MD
| 17:45 -17:55 | HIGH POWER SHORT DURATION FOR AF: EFFICIENCY & SAFETY Mihail G. Chelu, MD, PhD |
| 17:55 – 18:05 | PATHOPHYSIOLOGY OF THE THROMBOGENIC LEFT ATRIUM: TISSUE, SHAPE & FUNCTION |
| 18:05 – 18:15 | ATRIAL STRUCTURAL & FUNCTIONAL IMAGING FOR PREDICTING OUTCOMES IN AF James Thomas, MD |
| 18:15 – 18:25 | ADVANCES IN THE MANAGEMENT OF AF IN CONGESTIVE HEART FAILURE Rakesh Gopinathannair, MD, MA, FHRS |
| 18:25 – 18:35 | ADOPTING A SAME-DAY DISCHARGE STRATEGY AFTER AF ABLATION: FEASIBILITY & SAFETY Zayd Eldadah, MD |
| 18:35 – 18:50 | OPEN DISCUSSION |
| 18:50 | ADJOURNMENT |
Session 9
CHAIRS: Edward J. Schloss, MD, FHRS; Bassam Wanna, MD
| 17:45 -17:55 |
| HIGH POWER SHORT DURATION FOR AF: EFFICIENCY & SAFETY Mihail G. Chelu, MD, PhD |
| 17:55 – 18:05 |
PATHOPHYSIOLOGY OF THE THROMBOGENIC LEFT ATRIUM: TISSUE, SHAPE & FUNCTION |
| 18:05 – 18:15 |
| ATRIAL STRUCTURAL & FUNCTIONAL IMAGING FOR PREDICTING OUTCOMES IN AF James Thomas, MD |
| 18:15 – 18:25 |
| ADVANCES IN THE MANAGEMENT OF AF IN CONGESTIVE HEART FAILURE Rakesh Gopinathannair, MD, MA, FHRS |
| 18:25 – 18:35 |
| ADOPTING A SAME-DAY DISCHARGE STRATEGY AFTER AF ABLATION: FEASIBILITY & SAFETY Zayd Eldadah, MD |
| 18:35 – 18:50 |
| OPEN DISCUSSION |
| 18:50 |
| ADJOURNMENT |
CLOSING FIRESIDE CHATS
| 19:00 – 20:00 | CLOSING FIRESIDE CHATS Hosted by Janssen Pharmaceuticals |
| *This event is not part of the main WAF program nor is it designated for CME |
CLOSING FIRESIDE CHATS
| 19:00 – 20:00 |
| CLOSING FIRESIDE CHATS Hosted by Janssen Pharmaceuticals |
| *This event is not part of the main WAF program nor is it designated for CME |
Saturday, February 27, 2021
| 06:30 – 07:30 | CHECK-IN, EXHIBITS & BREAKFAST SNACKS |
| 06:30 – 07:15 | THE SAFETY & VALUE OF SAME-DAY DISCHARGE FOLLOWING ABLATION FOR A-FIB (NON-CME Program by Biosense Webster; separate from WAF) |
Saturday, February 27, 2021
| 06:30 – 07:30 |
| CHECK-IN, EXHIBITS & BREAKFAST SNACKS |
| 06:30 – 07:15 |
| THE SAFETY & VALUE OF SAME-DAY DISCHARGE FOLLOWING ABLATION FOR A-FIB (NON-CME Program by Biosense Webster; separate from WAF) |
Session 10
CHAIRS: Jonathan Hsu, MD; Andrea M. Russo, MD
| 07:30 – 07:40 | HOW I APPROACH MY RE-DO AF ABLATION PROCEDURE |
| 07:40 – 07:50 | LAAO POST-PROCEDURAL ANTI-THROMBOTIC TREATMENT: ASPIRIN, LOW-DOSE NOAC OR BOTH? Vivek Reddy, MD |
| 07:50 – 08:00 | REVERSE ATRIAL REMODELING AFTER ATRIAL FIBRILLATION ABLATION Dhiraj Gupta, FRCP |
| 08:00- 08:10 | THE DIGITAL HEALTH REVOLUTION DURING COVID-19: A HURDLE OR LONG-AWAITED CHANGE FOR AF PATIENTS? Christine Albert, MD, MPH |
| 08:10 – 08:20 | HEALTHY LIVES MATTER: WHAT COVID-19 HAS EXPOSED OF THE OVER WHELMING GLOBAL CRISIS IN PUBLIC HEALTH Nicholas S. Peters, MD |
| 08:20 – 08:40 | OPEN DISCUSSION |
Session 10
CHAIRS: Jonathan Hsu, MD; Andrea M. Russo, MD
| 07:30 – 07:40 |
HOW I APPROACH MY RE-DO AF ABLATION PROCEDURE |
| 07:40 – 07:50 |
| LAAO POST-PROCEDURAL ANTI-THROMBOTIC TREATMENT: ASPIRIN, LOW-DOSE NOAC OR BOTH? Vivek Reddy, MD |
| 07:50 – 08:00 |
| REVERSE ATRIAL REMODELING AFTER ATRIAL FIBRILLATION ABLATION Dhiraj Gupta, FRCP |
| 08:00- 08:10 |
| THE DIGITAL HEALTH REVOLUTION DURING COVID-19: A HURDLE OR LONG-AWAITED CHANGE FOR AF PATIENTS? Christine Albert, MD, MPH |
| 08:10 – 08:20 |
| HEALTHY LIVES MATTER: WHAT COVID-19 HAS EXPOSED OF THE OVER WHELMING GLOBAL CRISIS IN PUBLIC HEALTH Nicholas S. Peters, MD |
| 08:20 – 08:40 |
| OPEN DISCUSSION |
Session 11
MODERATORS: Nassir F. Marrouche, MD; Jeanne E. Poole, MD
| 08:40 – 09:05 | ROUNDTABLE: WHAT IS THE NEXT ABLATION RCT WE NEED THE MOST? MOVING BEYOND CASTLE-AF, CABANA, AFFIRM AND EAST-AF Johannes Brachmann, MD; Gerhard Hindricks, MD; Bradley P. Knight, MD; John Mandrola, MD; Douglas L. Packer, MD |
Session 11
MODERATORS: Nassir F. Marrouche, MD; Jeanne E. Poole, MD
| 08:40 – 09:05 |
| ROUNDTABLE: WHAT IS THE NEXT ABLATION RCT WE NEED THE MOST? MOVING BEYOND CASTLE-AF, CABANA, AFFIRM AND EAST-AF Johannes Brachmann, MD; Gerhard Hindricks, MD; Bradley P. Knight, MD; John Mandrola, MD; Douglas L. Packer, MD |
Session 12
MODERATORS: Christine Albert, MD, MPH; Frank Sachse, PhD
| 09:05 – 09:15 | STROKE & AF: TIME FOR A NEW RISK ASSESSMENT SCORE? M. Edip Gurol, MD |
| 09:15 – 09:25 | CHOOSING THE BEST AF ABLATION STRATEGY FOR EACH PATIENT: MY APPROACH Andrea Natale, MD, FHRS, VACC, FESC |
| 09:25 – 09:35 | THE IMPACT OF ABLATION LESIONS ON LA STRUCTURE & FUNCTION Philipp Sommer, MD |
| 09:35 – 09:45 | HOW TO PROTECT THE ESOPHAGUS DURING AF ABLATION Emile Daoud, MD |
| 09:45 – 09:55 | AF IN INHERITED ARRHYTHMIAS – A DIFFERENT BEAST? Andrew Krahn, MD |
| 09:55 – 10:10 | OPEN DISCUSSION |
| 10:10 – 10:25 | BREAK & EXHIBITS |
Session 12
MODERATORS: Christine Albert, MD, MPH; Frank Sachse, PhD
| 09:05 – 09:15 |
| STROKE & AF: TIME FOR A NEW RISK ASSESSMENT SCORE? M. Edip Gurol, MD |
| 09:15 – 09:25 |
| CHOOSING THE BEST AF ABLATION STRATEGY FOR EACH PATIENT: MY APPROACH Andrea Natale, MD, FHRS, VACC, FESC |
| 09:25 – 09:35 |
| THE IMPACT OF ABLATION LESIONS ON LA STRUCTURE & FUNCTION Philipp Sommer, MD |
| 09:35 – 09:45 |
| HOW TO PROTECT THE ESOPHAGUS DURING AF ABLATION Emile Daoud, MD |
| 09:45 – 09:55 |
| AF IN INHERITED ARRHYTHMIAS – A DIFFERENT BEAST? Andrew Krahn, MD |
| 09:55 – 10:10 |
| OPEN DISCUSSION |
| 10:10 – 10:25 |
| BREAK & EXHIBITS |
Session 13
MODERATORS: Elaine M. Hylek, MD, MPH; Bassam Wanna, MD
| 10:25 – 11:05 | ROUNDTABLE: CHALLENGING DECISIONS IN ANTICOAGULATION THERAPY: I WILL ANTICOAGULATE FOR STROKE PREVENTION WITHOUT PROOF OF AF IF…… Amin Al-Ahmad, MD; Thomas Deneke, MD; Gregory Feld, MD; M. Edip Gurol, MD; Mellanie True Hills, CSP |
Session 13
MODERATORS: Elaine Hylek, MD; Bassam Wanna, MD
| 10:25 – 11:05 |
| ROUNDTABLE: CHALLENGING DECISIONS IN ANTICOAGULATION THERAPY: I WILL ANTICOAGULATE FOR STROKE PREVENTION WITHOUT PROOF OF AF IF…… Amin Al-Ahmad, MD; Thomas Deneke, MD; Gregory Feld, MD; M. Edip Gurol, MD; Mellanie True Hills, CSP |
Session 14
CHAIRS: T. Jared Bunch, MD; Rohan Samson, MD
| 11:05 – 11:15 | ADDRESSING KEY KNOWLEDGE GAPS IN THE AF & HF INTERACTION: RESEARCH PRIORITIES Sana M. Al-Khatib, MD, MHS |
| 11:15 – 11:25 | ELECTROPORATION IS CHANGING THE WAY WE WILL ABLATE AF Moussa Mansour, MD |
| 11:25 – 11:35 | I STOP OAC AFTER ABLATION OF AF IF…. David J. Callans, MD |
| 11:35 – 11:45 | TARGETING FIBROSIS IN AF ABLATION: THE DECAAF TRIALS David J. Wilber, MD |
| 11:45 – 11:55 | ABLATE & CLOSE THE LEFT ATRIAL APPENDAGE: PATIENT SELECTION Dhanunjaya “DJ” Lakkireddy, MD |
| 11:55 – 12:10 | OPEN DISCUSSION |
| 12:10 – 13:10 | LUNCH & EXHIBITS |
| 12:30 – 13:00 | ICE ON ICE: BUILDING EFFICIENCIES FOR ADVANCED IMAGING (NON-CME Program by Biosense Webster; separate from WAF) |
Session 14
CHAIRS: T. Jared Bunch, MD; Rohan Samson, MD
| 11:05 – 11:15 |
| ADDRESSING KEY KNOWLEDGE GAPS IN THE AF & HF INTERACTION: RESEARCH PRIORITIES Sana M. Al-Khatib, MD, MHS |
| 11:15 – 11:25 |
| ELECTROPORATION IS CHANGING THE WAY WE WILL ABLATE AF Moussa Mansour, MD |
| 11:25 – 11:35 |
| I STOP OAC AFTER ABLATION OF AF IF…. David J. Callans, MD |
| 11:35 – 11:45 |
| TARGETING FIBROSIS IN AF ABLATION: THE DECAAF TRIALS David J. Wilber, MD |
| 11:45 – 11:55 |
| ABLATE & CLOSE THE LEFT ATRIAL APPENDAGE: PATIENT SELECTION Dhanunjaya “DJ” Lakkireddy, MD |
| 11:55 – 12:10 |
| OPEN DISCUSSION |
| 12:10 – 13:10 |
| LUNCH & EXHIBITS |
| 12:30 – 13:00 |
| ICE ON ICE: BUILDING EFFICIENCIES FOR ADVANCED IMAGING (NON-CME Program by Biosense Webster; separate from WAF) |
Session 15
CHAIRS: Dhiraj Gupta, FRCP, MD; Oussama Wazni, MD
| 13:10 – 13:20 | FACTOR XI FOR STROKE PREVENTION: HOPE OR HYPE? Elaine M. Hylek, MD, MPH |
| 13:20 – 13:30 | PAROXYSMAL, PERSISTENT & LONG-STANDING AF: TIME FOR A NEW CLASSIFICATION Jason Andrade, MD |
| 13:30 – 13:40 | EPI-CARDIAL BRIDGING & EPI-ENDO DISSOCIATION Roderick Tung, MD |
| 13:40 – 13:50 | ATRIAL FIBRILLATION & ATRIAL FLUTTER: DIFFERENCE IN REMODELING PROCESSES Sanjiv M. Narayan, MD, PhD |
| 13:50 – 14:00 | I USE DIGITAL HEALTH DEVICES FOR DETECTION OF AF IN MY PATIENTS, BUT…… David McManus, MD |
| 14:00 – 14:20 | OPEN DISCUSSION |
Session 15
CHAIRS: Dhiraj Gupta, FRCP, MD; Oussama Wazni, MD
| 13:10 – 13:20 |
| FACTOR XI FOR STROKE PREVENTION: HOPE OR HYPE? Elaine M. Hylek, MD, MPH |
| 13:20 – 13:30 |
| PAROXYSMAL, PERSISTENT & LONG-STANDING AF: TIME FOR A NEW CLASSIFICATION Jason Andrade, MD |
| 13:30 – 13:40 |
| EPI-CARDIAL BRIDGING & EPI-ENDO DISSOCIATION Roderick Tung, MD |
| 13:40 – 13:50 |
| ATRIAL FIBRILLATION & ATRIAL FLUTTER: DIFFERENCE IN REMODELING PROCESSES Sanjiv M. Narayan, MD, PhD |
| 13:50 – 14:00 |
| I USE DIGITAL HEALTH DEVICES FOR DETECTION OF AF IN MY PATIENTS, BUT…… David McManus, MD |
| 14:00 – 14:20 |
| OPEN DISCUSSION |
Session 16
CHAIRS: Jason Andrade, MD; Mikhael El Chami, MD
| 14:20 – 14:30 | MY MAZE PROCEDURE IN 2021 Ralph J. Damiano, Jr., MD |
| 14:30 – 14:40 | CLOSING THE APPENDAGE FOR PERSISTENT LAA CLOT Rahul N. Doshi, MD |
| 14:40 – 14:50 | WEARABLES IN EP: HRS GUIDANCE DOCUMENT Elaine Y. Wan, MD |
| 14:50 – 15:00 | COMBINING CARDIAC MRI & ARTIFICIAL INTELLIGENCE FOR PREDICTION OF ABLATION OUTCOMES Natalia Trayanova, PhD, FHRS, FAHA |
| 15:00 – 15:10 | ATRIAL FIBROSIS PREDICTS AF OCCURRENCE: INSIGHTS FROM ATRIAL MR IMAGING Brent D. Wilson, MD, PhD |
| 15:10 – 15:30 | OPEN DISCUSSION |
| 15:30 – 15:50 | BREAK & EXHIBITS |
Session 16
CHAIRS: Jason Andrade, MD; Mikhael El Chami, MD
| 14:20 – 14:30 |
| MY MAZE PROCEDURE IN 2021 Ralph J. Damiano, Jr., MD |
| 14:30 – 14:40 |
| CLOSING THE APPENDAGE FOR PERSISTENT LAA CLOT Rahul N. Doshi, MD |
| 14:40 – 14:50 |
| WEARABLES IN EP: HRS GUIDANCE DOCUMENT Elaine Y. Wan, MD |
| 14:50 – 15:00 |
| COMBINING CARDIAC MRI & ARTIFICIAL INTELLIGENCE FOR PREDICTION OF ABLATION OUTCOMES Natalia Trayanova, PhD, FHRS, FAHA |
| 15:00 – 15:10 |
| ATRIAL FIBROSIS PREDICTS AF OCCURRENCE: INSIGHTS FROM ATRIAL MR IMAGING Brent Wilson, MD |
| 15:10 – 15:30 |
| OPEN DISCUSSION |
| 15:30 – 15:50 |
| BREAK & EXHIBITS |
Session 17
CHAIRS: Janet K. Han, MD, FACC, FHRS
| 15:50 – 16:00 | IS OBESITY THE SOLE DRIVER BEHIND HFpEF LEADING TO AF? Rohan Samson, MD |
| 16:00 – 16:10 | ENDURANCE TRAINING, AF & STROKE RISK: IS IT THE SAME TYPE OF REMODELING? David Peritz, MD |
| 16:10 – 16:20 | THE MECHANISMS BEHIND AF & COGNITIVE IMPAIRMENT T. Jared Bunch, MD |
| 16:20 – 16:30 | LAA AS A THERAPEUTIC TARGET FOR AF Randall J. Lee, MD |
| 16:30 – 16:40 | PACS AND AF: CAUSE OR CONSEQUENCE? Edward P. Gerstenfeld, MD |
| 16:40 – 17:00 | OPEN DISCUSSION |
Session 17
CHAIRS: Janet K. Han, MD, FACC, FHRS
| 15:50 – 16:00 |
| IS OBESITY THE SOLE DRIVER BEHIND HFpEF LEADING TO AF? Rohan Samson, MD |
| 16:00 – 16:10 |
| ENDURANCE TRAINING, AF & STROKE RISK: IS IT THE SAME TYPE OF REMODELING? David Peritz, MD |
| 16:10 – 16:20 |
| THE MECHANISMS BEHIND AF & COGNITIVE IMPAIRMENT T. Jared Bunch, MD |
| 16:20 – 16:30 |
| LAA AS A THERAPEUTIC TARGET FOR AF Randall J. Lee, MD |
| 16:30 – 16:40 |
| PACS AND AF: CAUSE OR CONSEQUENCE? Edward P. Gerstenfeld, MD |
| 16:40 – 17:00 |
| OPEN DISCUSSION |
Session 18
MODERATORS: Janet K. Han, MD, FACC, FHRS; Edward J. Schloss, MD, FHRS
| 17:00 – 18:00 | ROUNDTABLE: #ASKWAF: ANYTHING ABOUT AFIB (Twitter Questions) Alexandru I. Costea, MD; John D. Day, MD; Mellanie True Hills, CSP; Leenhapong Navaravouong, MD; Christina J. Wurster, MBA |
| 18:00 | ADJOURNMENT |
Session 18
MODERATORS: Janet K. Han, MD, FACC, FHRS; Edward J. Schloss, MD, FHRS
| 17:00 – 18:00 |
| ROUNDTABLE: #ASKWAF: ANYTHING ABOUT AFIB (Twitter Questions) Alexandru I. Costea, MD; John D. Day, MD; MellanieTrue Hills, CSP; Leenhapong Navaravouong, MD; Christina J. Wurster, MBA |
| 18:00 |
| ADJOURNMENT |